Clinical analysis of continuing crizotinib treatment beyond disease progression in ALK-positive non-small-cell lung cancer patients

Hongmei Liu, Meijuan Huang, Yong Xu, Xiaojuan Zhou, J. Li, J. Wang, Feng Peng, Youling Gong, Zhangfan Ding, Junbing Zhu, Pei-wu Yu, Longjiang Li, Mingxiao Hou, L. Ren, Y. Wang, You LüAnnals 2016 · DOI

BibTeX
@article{liu2016clinical,
  author = {Hongmei Liu and Meijuan Huang and Yong Xu and Xiaojuan Zhou and J. Li and J. Wang and Feng Peng and Youling Gong and Zhangfan Ding and Junbing Zhu and Pei-wu Yu and Longjiang Li and Mingxiao Hou and L. Ren and Y. Wang and You Lü},
  title = {{Clinical analysis of continuing crizotinib treatment beyond disease progression in ALK-positive non-small-cell lung cancer patients}},
  journal = {Annals},
  year = {2016},
  doi = {10.1093/annonc/mdw383.66},
}

Loading related content...

Figure